RocketTickers

Poseida Therapeutics Announces FDA Clearance of Investigational

Long
NASDAQ:PSTX   Poseida Therapeutics, Inc.
PSTX: Poseida Therapeutics, Inc.
2021-08-30 08:00:00
Poseida Therapeutics Announces FDA Clearance of Investigational New Drug Application for P-BCMA-ALLO1, an Allogeneic CAR-T Candidate for Relapsed/Refractory Multiple Myeloma
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.